The assumption that a gain of (toxic) function underlies the pathogenic mechanism of LRRK2 mutations has incited many groups to overexpress LRRK2 variants in cell culture, in order to generate a representative cellular PD model and obtain insight in the mechanisms by which LRRK2 mutations can induce neurodegeneration. This evidence concerns the gene LRRK2 and Parkinson disease.